Japanese encephalitis (JE) is
inflammation of brain which is caused by Japanese encephalitis virus
(JEV). This virus belongs to family Flaviviradae. JEV is considered as the most important cause of encephalitis in Asia. JEV is mosquito born flavivirus, belonging to same genus as dengue. It is spread by mosquitoes of Culex sp. Pig
and birds are reservoirs of the virus and help in spreading and
maintaining the JEV cycle. The disease caused by the virus has no cure.
Effective vaccines are available which can prevent JE. JE vaccine is
recommended to be integrated into national immunization schedule where
JE disease is a public concern.
Report Overview @ https://www.transparencymarketresearch.com/japanese-encephalitis-vaccine-market.html
The global Japanese encephalitis vaccine
market is estimated to grow at a significant rate over the forecast
period. According to WHO, the estimated annual number of clinical cases
of JE are about 68000 globally. Thus rise in prevalence and incidence of
the disease is one of the most important factor expected to drive the
growth of global Japanese encephalitis vaccine market during the
forecast period. Furthermore, rise in awareness about the disease,
increase in travel and tourism, government initiative to eradicate the
disease, pig farming, entry of new vaccine manufacturers, developed R
& D etc, increasing mosquito nuisance are few other factors fuelling
the growth of the global Japanese encephalitis market through 2025.
Factors such as stringent government regulation regarding efficacy and
safety, lack of awareness lack of supply of the vaccine in remote areas
can be the major restraining factors for global Japanese encephalitis
vaccine market during the forecast period.
The global Japanese encephalitis vaccine
market can be segmented into product type, distribution channel and
regions. On the basis of product type, the global Japanese encephalitis
vaccine market can be divided into mouse brain derived vaccine, live
attenuated vaccine, live recombinant vaccine, inactivated Vero-cell
derived vaccine. Vero cell derived vaccine segment is expected to
account for a significant share of the market during the forecast period
since mouse brain derived vaccine are being replaced cell based
vaccine, due to higher efficacy and safety and animal ethical
regulations. Based on the distribution channel the global JE vaccine
market can be divided into hospital pharmacies, retail pharmacies and
E-commerce.
Geographically the global Japanese
encephalitis vaccine market is divided into North America, Latin
America, Europe, Asia Pacific, and Middle East and Africa. North America
is anticipated to dominate the human rabies vaccine market with the
largest share during the forecast period. Surge in investment from
government and public sector, programs to eradicate JE and yellow fever
from the region etc are few factors propelling the growth of the global
market in the North America. Furthermore, rise in awareness, robust
research activities on yellow fever and JEV, high health care
expenditure etc. are some other factors leading to market growth in the
region. Asia Pacific market is anticipated to register a faster growth
rate during the forecast period. The Asia Pacific is the most lucrative
market due to high prevalence of the JE, government induced immunization
programs, growing investment in R & D sector, entry of new vaccine
manufacturers in the countries like India and China, increase number of
travelers in the region, medical tourism etc. Furthermore, increase in
pig farms, poultry and mosquito nuisance in the region etc, are some of
the factors anticipated to drive the growth of market in the region.
Some of the prominent players operating
in the global Japanese encephalitis vaccine market are Valneva SE,
Bharat Biotech, Sanofi Pasteur SA, Biological E Chengdu Institute of
Biological Products Co, Ltd and others.
The report offers a comprehensive
evaluation of the market. It does so via in-depth qualitative insights,
historical data, and verifiable projections about market size. The
projections featured in the report have been derived using proven
research methodologies and assumptions. By doing so, the research report
serves as a repository of analysis and information for every facet of
the market, including but not limited to: Regional markets, technology,
types, and applications.
No comments:
Post a Comment